It is proposed to determine the structural requirements for the functional activities of interleukin-8, a protein inflammatory mediator responsible for diverse pathologies. The long term objectives are to provide a hypothesis for the receptor bound form and a basis set of compounds with modified activities that will lead to the design of novel anti- inflammatory drugs.
The specific aims are 1) to determine the individual residues and structural features that are critical for its multiple biological functions, 2) design and generate more efficient antagonists of IL-8 actions, based on our low affinity antagonists, and 3) design a minimal peptide that mimics the activities of the mature protein. The experimental design will be to model and synthesize analogs, based on the 3-dimensional structure, that maintain the overall fold but result in local changes so that the structural and functional roles of individual regions/residues can be assessed. The analogs proposed include hybrids between homologous structures with no function, substitutions, covalent dimers, heterodimers, dimer destabilizing modifications, and conformationally restricted analogs. The proposed analogs will be progressively adjusted as information is acquired from the initial experiments so that profiles of allowed and disallowed substitutions at key sites can be obtained as efficiently as possible. Use will be made of coded and non-coded amino acids. The effects of the changes will be determined structurally by CD spectroscopy and where appropriate 2D-NMR spectroscopic techniques, and the functional changes by assaying the analogs for receptor binding, chemotaxis and exocytosis activities and where appropriate inhibitors of these activities, as well as intracellular calcium induction and respiratory burst activities. Analogs will be chemically synthesized by automated Merrifield methods and characterized physiochemically for authenticity and structure. The chemical synthesis approach is crucial to this study because it will allow synthesis of analogs with unambiguous structure in a facile and timely manner and allows the use of non-coded amino acids. Using this approach will be realistic to provide a detailed understanding of IL-8 structure-activity relations within the prescribed time period.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM050969-01
Application #
2189215
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Project Start
1994-04-01
Project End
1997-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of British Columbia
Department
Type
DUNS #
800772162
City
Vancouver
State
BC
Country
Canada
Zip Code
V6 1-Z3
Wolf, M; Delgado, M B; Jones, S A et al. (1998) Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2. Eur J Immunol 28:164-70
Jones, S A; Dewald, B; Clark-Lewis, I et al. (1997) Chemokine antagonists that discriminate between interleukin-8 receptors. Selective blockers of CXCR2. J Biol Chem 272:16166-9
Ponath, P D; Qin, S; Ringler, D J et al. (1996) Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 97:604-12
Gong, J H; Uguccioni, M; Dewald, B et al. (1996) RANTES and MCP-3 antagonists bind multiple chemokine receptors. J Biol Chem 271:10521-7
Kim, K S; Rajarathnam, K; Clark-Lewis, I et al. (1996) Structural characterization of a monomeric chemokine: monocyte chemoattractant protein-3. FEBS Lett 395:277-82
Granelli-Piperno, A; Moser, B; Pope, M et al. (1996) Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors. J Exp Med 184:2433-8
Clark-Lewis, I; Kim, K S; Rajarathnam, K et al. (1995) Structure-activity relationships of chemokines. J Leukoc Biol 57:703-11
Gong, J H; Clark-Lewis, I (1995) Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues. J Exp Med 181:631-40
Kim, K S; Clark-Lewis, I; Sykes, B D (1994) Solution structure of GRO/melanoma growth stimulatory activity determined by 1H NMR spectroscopy. J Biol Chem 269:32909-15
Clark-Lewis, I; Dewald, B; Loetscher, M et al. (1994) Structural requirements for interleukin-8 function identified by design of analogs and CXC chemokine hybrids. J Biol Chem 269:16075-81

Showing the most recent 10 out of 11 publications